Retraction Note: MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer (Scientific Reports, (2015), 5, 1, (13677), 10.1038/srep13677);MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yang, Lihua ^a   Yang, Jie ^a   Li, Jingqiu ^a   Shen, Xingkai ^a   Le, Yanping ^a   Zhou, Chengwei ^b   Wang, Shaomin ^a   Zhang, Shun ^c   Xu, Dazhi ^d   Gong, Zhaohui ^a  

^a NINGBO UNIVERSITY   (China)

^b Department of Chest Surgery ^*  (United States)

^c Ningbo No7 Hospital   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN33 MICRORNA, HUMAN; NUCLEAR PROTEIN; TUMOR MARKER; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ANIMAL; DRUG SCREENING; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; MOLECULAR GENETICS; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE, SCID; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; TWIST-RELATED PROTEIN 1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84940871260     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-021-88178-8     Document Type: Erratum

References (45)

1. Herbst, R. S., Heymach, J. V. & Lippman, S. M. Lung cancer. N Engl J Med 359, 1367-1380 (2008).
2. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559-1564 (2011).
3. Kalluri R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428 (2009).
4. Tiwari, N., Gheldof, A., Tatari, M. & Christofori, G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 22, 194-207 (2012).
5. Kang, Y. & Massague, J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118, 277-279 (2004).
6. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
7. Haga, C. L. & Phinney, D. G. MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem 287, 42695-42707 (2012).
8. Dong, P. et al. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 10, 99 (2011).
9. Tellez, C. S. et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res 71, 3087-3097 (2011).
10. Najafi-Shoushtari, S. H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566-1569 (2010).
11. Marquart, T. J., Allen, R. M., Ory, D. S. & Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA 107, 12228-12232 (2010).
12. Thomas, M. et al. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 31, 918-928 (2012).
13. Cirera-Salinas, D. et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 11, 922-933 (2012).
14. Pang, W. et al. Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer. Mol Cancer 13, 240 (2014).
15. Zhong, Z., Dong, Z., Yang, L. & Gong, Z. miR-21 induces cell cycle at S phase and modulates cell proliferation by downregulating hMSH2 in lung cancer. J Cancer Res Clin Oncol 138, 1781-1788 (2012).
16. Zhong, Z., Dong, Z., Yang, L., Chen, X. & Gong, Z. MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. Tumour Biol 34, 1959-1965 (2013).
17. Pan, L. et al. Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells. Mol Cell Biochem 355, 257-263 (2011).
18. Dong, Z., Zhong, Z., Yang, L., Wang, S. & Gong, Z. MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Lett 343, 249-257 (2014).
19. Shiota, M. et al. Clusterin mediates TGF-beta-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells. Cancer Res 72, 5261-5272 (2012).
20. Yang, W. H. et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 14, 366-374 (2012).
21. Huang, W. C. et al. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res 74, 751-764 (2014).
22. Hurst, D. R., Edmonds, M. D. & Welch, D. R. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69, 7495-7498 (2009).
23. Lamouille, S., Subramanyam, D., Blelloch, R. & Derynck, R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol 25, 200-207 (2013).
24. Wellner, U. et al. The EMT-Activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11, 1487-1495 (2009).
25. Bracken, C. P. et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelialmesenchymal transition. Cancer Res 68, 7846-7854 (2008).
26. Siemens, H. et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10, 4256-4271 (2011).
27. Kim, N. H. et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 195, 417-433 (2011).
28. Xu, Q., Sun, Q., Zhang, J., Yu, J., Chen, W. & Zhang, Z. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 34, 539-549 (2013).
29. Zhang, J. P., Zeng, C., Xu, L., Gong, J., Fang, J. H. & Zhuang, S. M. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene 33, 4069-4076 (2014).
30. Tsuchiya, S. et al. MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res 37, 3821-3827 (2009).
31. Kuo, P. L., Liao, S. H., Hung, J. Y., Huang, M. S. & Hsu, Y. L. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta 1830, 3756-3766 (2013).
32. Ibrahim, A. F., Weirauch, U., Thomas, M., Grunweller, A., Hartmann, R. K. & Aigner A. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71, 5214-5224 (2011).
33. Rice, S. J. et al. MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1). J Biol Chem 288, 16348-16360 (2013).
34. Yin, Z., Xu, X. L. & Frasch, M. Regulation of the twist target gene tinman by modular cis-regulatory elements during early mesoderm development. Development 124, 4971-4982 (1997).
35. Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudinlow and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107, 15449-15454 (2010).
36. Ansieau, S. et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79-89 (2008).
37. Puisieux, A., Valsesia-Wittmann, S. & Ansieau, S. A twist for survival and cancer progression. Br J Cancer 94, 13-17 (2006).
38. Ansieau, S., Morel, A. P., Hinkal, G., Bastid, J. & Puisieux, A. TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29, 3173-3184 (2010).
39. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
40. Chen, H. F. et al. Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. Nat Commun 5, 4697 (2014).
41. Li, L. Z. et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1. Carcinogenesis 35, 469-478 (2014).
42. Dong, P., Kaneuchi, M., Watari, H., Sudo, S. & Sakuragi, N. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. Mol Carcinog 53, 349-359 (2014).
43. Hernandez, J. M. et al. miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma. Ann Surg Oncol 20 Suppl 3, 625-635 (2013).
44. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007).
45. Di Martino, M. T. et al. Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence. Clin Cancer Res 18, 6260-6270 (2012).